MedPath

NOVARTIS (SINGAPORE) PTE LTD

🇸🇬Singapore
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

181

HSA:180
NMPA:1

Drug Approvals

Olopatadine Hydrochloride Eye Drops

Product Name
盐酸奥洛他定滴眼液
Approval Number
国药准字HJ20200062
Approval Date
Dec 25, 2020
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.